Correlation Between Armata Pharmaceuticals and Valneva SE
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Valneva SE ADR, you can compare the effects of market volatilities on Armata Pharmaceuticals and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Valneva SE.
Diversification Opportunities for Armata Pharmaceuticals and Valneva SE
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Armata and Valneva is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Valneva SE go up and down completely randomly.
Pair Corralation between Armata Pharmaceuticals and Valneva SE
Given the investment horizon of 90 days Armata Pharmaceuticals is expected to under-perform the Valneva SE. In addition to that, Armata Pharmaceuticals is 1.15 times more volatile than Valneva SE ADR. It trades about -0.01 of its total potential returns per unit of risk. Valneva SE ADR is currently generating about 0.01 per unit of volatility. If you would invest 559.00 in Valneva SE ADR on November 6, 2024 and sell it today you would lose (22.00) from holding Valneva SE ADR or give up 3.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Armata Pharmaceuticals vs. Valneva SE ADR
Performance |
Timeline |
Armata Pharmaceuticals |
Valneva SE ADR |
Armata Pharmaceuticals and Valneva SE Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Armata Pharmaceuticals and Valneva SE
The main advantage of trading using opposite Armata Pharmaceuticals and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.The idea behind Armata Pharmaceuticals and Valneva SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |